financial status of the Company and help reduce the financial burden increasing the liquidity and cash flow of the Company. 7. Use of Proceeds from the Assets Disposal Transaction TO repay the debts, decrease
) (1,612.81) (1,350.14) Net Cash Used in Financing Activities (54.66) (757.33) (680.20) Net Increase (Decrease) in Cash and Cash Equivalents 322.76 (281.62) 425.39 Cash and Cash Equivalents at the Beginning
(Before Change) Reappraisal Basis (After Change) Increase (Decrease) Assets - Lands - Allowance for Impairment Losses of Lands 553.29 - 795.12 - 249.70 (7.87) Liabilities - Deferred tax liabilities - 49.94
) (10.3) 5 Operating results of the Bank and subsidiaries for 3Q18 comparing with 3Q17 The consolidated net profit for 3Q18 totaled Baht 1,551 million, a decrease of 10.0% yoy, of which Baht 157 million was
) (10.3) 5 Operating results of the Bank and subsidiaries for 3Q18 comparing with 3Q17 The consolidated net profit for 3Q18 totaled Baht 1,551 million, a decrease of 10.0% yoy, of which Baht 157 million was
in March 2019 and March 2020 respectively; • Interest expense from ABPIF y-on-y: A 28.6% decrease in Q1’2020 to THB 40 million based on changes in benefits transferred from the business operation of
million, a decrease of 41.6% comparing to Baht 1,369 million in 1Q19. The comprehensive income included revaluation of available-for-sale securities as a result of the capital market volatility. Operating
million, a decrease of 41.6% comparing to Baht 1,369 million in 1Q19. The comprehensive income included revaluation of available-for-sale securities as a result of the capital market volatility. Operating
runs the drug business and a small hospital by Modern Company without loan Adjust, increase and decrease, an additional 0.25% discount rate will be valued between 278.25-312.67 million Baht 7. Criteria
Pittayachai 4 Co., Ltd. at the Central Office for Machinery Registration, Department of Industrial Works, Ministry of Industry. As a result, the debenture debt will decrease by 55,000,000 Baht (Fifty Five